[1]
|
Himmelseher, S. and Durieux, M.E. (2005) Ketamine for Perioperative Pain Management. Anesthesiology, 102, 211-220. https://doi.org/10.1097/00000542-200501000-00030
|
[2]
|
Reynolds, S. (2017) Ketamine: Not Just for Pediatric Sedtion? Clinical Pediatric Emergency Medicine, 18, 286-291. https://doi.org/10.1016/j.cpem.2017.09.008
|
[3]
|
Covvey, J.R. and Lowe, D.K. (2012) Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder. Annals of Pharmacotherapy, 46, 117-123. https://doi.org/10.1345/aph.1Q371
|
[4]
|
Motov, S., et al. (2018) Continuous Intravenous Sub-Dissociative Dose Ketamine Infusion for Managing Pain in the Emergency Department. The Western Journal of Emergency Medicine, 19, 559-566.
https://doi.org/10.5811/westjem.2017.12.36174
|
[5]
|
Abdallah, C.G., Averill, L.A. and Krystal, J.H. (2015) Ketamine as a Promising Prototype for a New Generation of Rapid-Acting Antidepressants. Annals of the New York Academy of Sciences, 1344, 66-77. https://doi.org/10.1111/nyas.12718
|
[6]
|
Jonkman, K., Dahan, A., van de Donk, T., Aarts, L., Niesters, M. and van Velzen, M. (2017) Ketamine for Pain. F1000Research, 6, F1000. https://doi.org/10.12688/f1000research.11372.1
|
[7]
|
Niesters, M., Martini, C. and Dahan, A. (2014) Ketamine for Chronic Pain: Risks and Benefits. British Journal of Clinical Pharmacology, 77, 357-367. https://doi.org/10.1111/bcp.12094
|
[8]
|
Bell, R.F., Dahl, J.B., Moore, R.A. and Kalso, E. (2005) Peri-Operative Ketamine for Acute Post-Operative Pain: A Quantitative and Qualitative Systematic Review (Cochrane Review). Acta Anaesthesiologica Scandinavica, 49, 1405-1428. https://doi.org/10.1111/j.1399-6576.2005.00814.x
|
[9]
|
Lee, E.N. and Lee, J.H. (2016) The Effects of Low-Dose Ketamine on Acute Pain in an Emergency Setting: A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0165461.
https://doi.org/10.1371/journal.pone.0165461
|
[10]
|
Dahmani, S., Michelet, D., Abback, P.S., Wood, C., Brasher, C., Nivoche, Y. and Mantz, J. (2011) Ketamine for Perioperative Pain Management in Children: A Meta-Analysis of Published Studies. Pediatric Anesthesia, 21, 636-652. https://doi.org/10.1111/j.1460-9592.2011.03566.x
|
[11]
|
McNicol, E.D., Schumann, R. and Haroutounian, S. (2014) A Systematic Review and Meta-Analysis of Ketamine for the Prevention of Persistent Post-Surgical Pain. Acta Anaesthesiologica Scandinavica, 58, 1199-1213. https://doi.org/10.1111/aas.12377
|
[12]
|
Golembiewski, J. (2017) Ketamine What Is Old Is New Again. Journal of PeriAnesthesia Nursing, 32, 660-663. https://doi.org/10.1016/j.jopan.2017.09.003
|
[13]
|
Radvansky, B.M., Shah, K., Parikh, A., Sifonios, A.N., Le, V. and Eloy, J.D. (2015) Role of Ketamine in Acute Postoperative Pain Management: A Narrative Review. BioMed Research International, 2015, Article ID: 749837. https://doi.org/10.1155/2015/749837
|
[14]
|
Rascón-Martínez, D.M., et al. (2018) Advantages of Ketamine as a Perioperative Analgesic. Revista Médica del Hospital General de México, 81, 253-261. https://doi.org/10.1016/j.hgmx.2016.10.007
|
[15]
|
Jouguelet-Lacoste, J., La Colla, L., Schilling, D. and Chelly, J.E. (2015) The Use of Intravenous Infusion or Single Dose of Low-Dose Ketamine for Postoperative Analgesia: A Review of the Current Literature. Pain Medications, 16, 383-403. https://doi.org/10.1111/pme.12619
|
[16]
|
Soto, E., Stewart, D.R., Mannes, A.J., Ruppert, S.L., Baker, K., Zlott, D., Handel, D. and Berger, A.M. (2012) Oral Ketamine in the Palliative Care Setting: A Review of the Literature and Case Report of a Patient with Neurofibromatosis Type 1 and Glomus Tumor-Associated Complex Regional Pain Syndrome. American Journal of Hospice and Palliative Care, 29, 308-317. https://doi.org/10.1177/1049909111416345
|
[17]
|
Hawksworth, C., et al. (1998) Intrathecal Anesthesia with Ketamine. Regional Anesthesia & Pain Medicine, 23, 283-288. https://doi.org/10.1097/00115550-199823030-00010
|
[18]
|
Daly, E.J., Singh, J.B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R.C., Thase, M.E., Winokur, A., Van Nueten, L., Manji, H., et al. (2018) Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry, 75, 139-148. https://doi.org/10.1001/jamapsychiatry.2017.3739
|
[19]
|
Huge, V., Lauchart, M., Magerl, W., Schelling, G., Beyer, A., Thieme, D. and Azad, S.C. (2010) Effects of Low-Dose Intranasal (S)-Ketamine in Patients with Neuropathic Pain. European Journal of Pain, 14, 387-394. https://doi.org/10.1016/j.ejpain.2009.08.002
|
[20]
|
Laskowski, K., Stirling, A., McKay, W.P. and Lim, H.J. (2011) A Systematic Review of Intravenous Ketamine for Postoperative Analgesia. Canadian Journal of Anesthesia, 58, 911-923.
https://doi.org/10.1007/s12630-011-9560-0
|
[21]
|
Billy Sin, T.T., et al. (2017) The Use of Ketamine for Acute Treatment of Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Emergency Medicine, 52, 601-608. https://doi.org/10.1016/j.jemermed.2016.12.039
|
[22]
|
Zhu, J., Xie, H., Zhang, L., Chang, L. and Chen, P. (2018) Efficiency and Safety of Ketamine for Pain Relief after Laparoscopic Cholecystectomy: A Meta-Analysis from Randomized Controlled Trials. International Journal of Surgery, 49, 1-9. https://doi.org/10.1016/j.ijsu.2017.11.031
|
[23]
|
Price, R.B. and Mathew, S.J. (2015) Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions. CNS Drugs, 29, 181-188. https://doi.org/10.1007/s40263-015-0232-4
|
[24]
|
Bromet, E., Andrade, L.H., Hwang, I., Sampson, N.A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) Cross-National Epidemiology of DSM-IV Major Depressive Episode. BMC Medicine, 9, Article No. 90. https://doi.org/10.1186/1741-7015-9-90
|
[25]
|
Oremus, C., Oremus, M., McNeely, H., Losier, B., Parlar, M., King, M., Hasey, G., Fervaha, G., Graham, A.C., Gregory, C., et al. (2015) Effects of Electroconvulsive Therapy on Cognitive Functioning in Patients with Depression: Protocol for a Systematic Review and Meta-Analysis. BMJ Open, 5, e006966. https://doi.org/10.1136/bmjopen-2014-006966
|
[26]
|
Brooke, S.J., Galvez, V., Shelker, W. and Loo, C.K. (2018) Side-Effects Associated with Ketamine Use in Depression: A Systematic Review. The Lancet Psychiatry, 5, 65-78. https://doi.org/10.1016/S2215-0366(17)30272-9
|
[27]
|
Li, N., Lee, B., Liu, R.J., Banasr, M., Dwyer, J.M., Iwata, M., Li, X.Y., Aghajanian, G. and Duman, R.S. (2010) mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists. Science, 329, 959-964. https://doi.org/10.1126/science.1190287
|
[28]
|
Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B. and Charney, D.S. (1994) Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans. Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses. Archives of General Psychiatry, 51, 199-214. https://doi.org/10.1001/archpsyc.1994.03950030035004
|
[29]
|
Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S. and Krystal, J.H. (2000) Antidepressant Effects of Ketamine in Depressed Patients. Biological Psychiatry, 47, 351-354. https://doi.org/10.1016/S0006-3223(99)00230-9
|
[30]
|
Zarate, C.A., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S. and Manji, H.K. (2006) A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Archives of General Psychiatry, 63, 856-864. https://doi.org/10.1001/archpsyc.63.8.856
|
[31]
|
Feifel, B.M., Boggie, D. and Lee, K. (2017) Low-Dose Ketamine for Treatment Resistant Depression in an Academic Clinical Practice Setting. Journal of Affective Disorders, 221, 283-288. https://doi.org/10.1016/j.jad.2017.06.043
|
[32]
|
Price, R.B., Nock, M.K., Charney, D.S. and Mathew, S.J. (2009) Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression. Biological Psychiatry, 66, 522-526. https://doi.org/10.1016/j.biopsych.2009.04.029
|
[33]
|
Arai, Y., Onishi, H., Oishi, K., Takeuchi, H. and Yoshida, O. (1992) Value of Prostate-Specific Antigen Measurements with Newly Developed Enzyme Immunoassay (MARKIT-M PA). Hinyokika Kiyo, 38, 1129-1134.
|
[34]
|
Hashimoto, K. (2019) Rapid-Acting Antidepressant Ketamine, Its Metabolites and Other Candidates: A Historical Overview and Future Perspective. Psychiatry and Clinical Neurosciences, 73, 613-627. https://doi.org/10.1111/pcn.12902
|
[35]
|
Fedgchin, M., Trivedi, M., Daly, E.J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined with a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). International Journal of Neuropsychopharmacology, 22, 616-630. https://doi.org/10.1093/ijnp/pyz039
|
[36]
|
Glue, P., Neehoff, S., Sabadel, A., Broughton, L., Le Nedelec, M., Shadli, S., McNaughton, N. and Medlicott, N.J. (2019) Effects of Ketamine in Patients with Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders: Exploratory Double-Blind Psychoactive-Controlled Replication Study. Journal of Psychopharmacology, 34, 267-272. https://doi.org/10.1177/0269881119874457
|
[37]
|
Jaspersen, D. (1992) The Diagnosis and Therapy of Dieulafoy’s Bleeding. Deutsche Medizinische Wochenschrift, 117, 1447-1449. https://doi.org/10.1055/s-2008-1062463
|
[38]
|
JeffRiddella, A., Bengiamin, R., Hendey, G.W. and Armenian, P. (2017) Ketamine as a First-Line Treatment for Severely Agitated Emergency Department Patients. The American Journal of Emergency Medicine, 35, 1000-1004. https://doi.org/10.1016/j.ajem.2017.02.026
|
[39]
|
Pourmand, A., Mazer-Amirshahi, M., Royall, C., Alhawas, R. and Shesser, R. (2017) Low Dose Ketamine Use in the Emergency Department, a New Direction in Pain Management. American Journal of Emergency Medicine, 35, 918-921. https://doi.org/10.1016/j.ajem.2017.03.005
|
[40]
|
Motov, S., Mai, M., Pushkar, I., Likourezos, A., Drapkin, J., Yasavolian, M., Brady, J., Homel, P. and Fromm, C. (2017) A Prospective Randomized, Double-Dummy Trial Comparing IV Push Low Dose Ketamine to Short Infusion of Low Dose Ketamine for Treatment of Pain in the ED. American Journal of Emergency Medicine, 35, 1095-1100. https://doi.org/10.1016/j.ajem.2017.03.004
|
[41]
|
Le Cornec, C., Lariby, S., Brenckmann, V., Hardouin, J.B., Ecoffey, C., Le Pottier, M., Fradin, P., Broch, H., Kabbaj, A., Auffret, Y., et al. (2018) Is Intravenously Administered, Subdissociative-Dose KETA-mine Non-Inferior to MORPHine for Prehospital Analgesia (The KETAMORPH Study): Study Protocol for a Randomized Controlled Trial. Trials, 19, 260. https://doi.org/10.1186/s13063-018-2634-3
|
[42]
|
Bowers, K.J., McAllister, K.B., Ray, M. and Heitz, C. (2017) Ketamine as an Adjunct to Opioids for Acute Pain in the Emergency Department: A Randomized Controlled Trial. Academic Emergency Medicine, 24, 676-685. https://doi.org/10.1111/acem.13172
|
[43]
|
Beaudoin, F.L., Lin, C., Guan, W. and Merchant, R.C. (2014) Low-Dose Ketamine Improves Pain Relief in Patients Receiving Intravenous Opioids for Acute Pain in the Emergency Department: Results of a Randomized, Double-Blind, Clinical Trial. Academic Emergency Medicine, 21, 1193-1202. https://doi.org/10.1111/acem.12510
|
[44]
|
Todd, K.H. (2017) A Review of Current and Emerging Approaches to Pain Management in the Emergency Department. Pain and Therapy, 6, 193-202. https://doi.org/10.1007/s40122-017-0090-5
|